Acme Generics Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Acme Generics Private Limited Pharmaceutical Export Portfolio Dataset — 6 Products, $7.1M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Acme Generics Private Limited — Pharmaceutical Exporter Profile (2026) | 6 Products, $7.1M Trade | TransData Nexus

Who is Acme Generics Private Limited? — Company Overview & Market Position

Acme Generics Private Limited is a privately held pharmaceutical company based in Mohali, Punjab, India. Established on July 30, 2021, the company specializes in the manufacturing and export of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. The Corporate Identification Number (CIN) assigned to Acme Generics is U24100PB2021PTC056566. As of March 2026, the company reports an authorized capital of ₹121.44 crore and a paid-up capital of ₹120.10 crore. The registered office is located at Plot No. 132, 2nd Floor, Sector 82, JLPL, Mohali, Punjab, 140308.

Acme Generics has demonstrated significant growth since its inception, with a total export value of $7.1 million USD and 285 shipments across six products in five therapeutic categories. The company's product portfolio is notably concentrated, with the top five products accounting for 93.6% of total exports. This concentration underscores the company's strategic focus on specific high-demand pharmaceutical formulations.

What Does Acme Generics Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Levothyroxine$3.4M 2Acetaminophen$1.1M 3Loperamide$910.9K 4Salicylic$686.1K 5Mycophenolate$612.4K 6Acetylsalicylic$450.9K

Acme Generics Private Limited Therapeutic Categories — 5 Specializations

Acme Generics Private Limited operates across 5 therapeutic categories, with Diabetes & Endocrine (47.7%), Combination Drugs (16.0%), Analgesics & Antipyretics (14.8%) representing the largest segments by export value. The portfolio is concentrated — the top 5 products account for 94% of total exports.

Diabetes & Endocrine

1 products · 47.7% · $3.4M

Combination Drugs

2 products · 16.0% · $1.1M

Analgesics & Antipyretics

1 products · 14.8% · $1.1M

Gastrointestinal

1 products · 12.8% · $910.9K

Immunosuppressants

1 products · 8.6% · $612.4K

Product Portfolio — Top 6 by Export Value

Acme Generics Private Limited exports 6 pharmaceutical products across 5 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Levothyroxine	Diabetes & Endocrine	$3.4M	190	4.4%

Key Metrics

Total Trade$7.1M

Products6

Shipments285

Categories5

#1 Rankings0

Top 5 Concentration93.6%

Top Categories

Diabetes & Endocrine47.7%

Combination Drugs16.0%

Analgesics & Antipyretics14.8%

Last updated: March 28, 2026

Acme Generics Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Acme Generics operates state-of-the-art manufacturing facilities designed to produce a diverse range of pharmaceutical products. The company's manufacturing plant is strategically located in Baddi, Himachal Pradesh, a region known for its pharmaceutical manufacturing infrastructure. The facility boasts an annual production capacity of 60 million general liquid and lyophilized vials, 60 million liquid and lyophilized vials for oncology, 30 million three-piece ophthalmic containers, and 24 million pre-filled syringes and cartridges. This expansive capacity enables Acme Generics to meet both domestic and international demand effectively.

Acme Generics Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Acme Generics has achieved significant milestones in the U.S. market, with 38 Abbreviated New Drug Applications (ANDAs) approved and 18 ANDAs filed and under review. The company's manufacturing facility has been audited and approved by the U.S. Food and Drug Administration (FDA), affirming its compliance with stringent U.S. regulatory standards. This approval not only facilitates the marketing of Acme Generics' products in the U.S. but also enhances the company's credibility in other regulated markets.

2WHO & EU GMP

Acme Generics has obtained Good Manufacturing Practice (GMP) certifications from the World Health Organization (WHO) and the European Union (EU). These certifications validate the company's commitment to maintaining high-quality manufacturing standards and its capability to produce pharmaceutical products that meet international quality benchmarks. The EU GMP certification, in particular, opens avenues for the company to market its products across EU member states, thereby expanding its reach in the European market.

3CDSCO & Indian Regulatory

In India, Acme Generics holds manufacturing licenses from the Central Drugs Standard Control Organisation (CDSCO), ensuring compliance with national regulatory standards. The company has also obtained approvals from state drug controllers and export No Objection Certificates (NOCs), facilitating the export of its products to various international markets. These regulatory clearances reflect Acme Generics' adherence to both domestic and international pharmaceutical regulations.

4Recent Regulatory Actions

As of March 2026, there are no publicly available records indicating any Form 483 observations, warning letters, or import alerts issued against Acme Generics Private Limited. This absence of adverse regulatory actions suggests that the company maintains a strong compliance record and adheres to the regulatory standards set by authorities such as the FDA, WHO, and CDSCO.

TransData Nexus Research · FDA Orange Book, WHO PQ database, EMA GMP registry, CDSCOMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Supplier Matching: Acme Generics Private Limited identified across shipments using name normalization.
2.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
3.Market Share: Calculated per product as Acme Generics Private Limited's capped value divided by total Indian exports for that product.
4.Shipment Count: Based on 285 individual customs records matching Acme Generics Private Limited.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

6 Products Tracked

5 therapeutic categories

Expert-Reviewed

By pharmaceutical trade specialists

Acme Generics Private Limited

Acme Generics Private Limited — Export Portfolio & Destination Treemap

Who is Acme Generics Private Limited? — Company Overview & Market Position

What Does Acme Generics Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

Acme Generics Private Limited Therapeutic Categories — 5 Specializations

Product Portfolio — Top 6 by Export Value

Key Metrics

Top Categories

Acme Generics Private Limited — Corporate Profile & Information

1Corporate Overview

2Manufacturing Facilities

Top Export Routes

Related Analysis

Need Detailed Data?

3Key Leadership

Where Does Acme Generics Private Limited Export? — Destination Intelligence

1Regulated Markets

2Emerging Markets

3Geographic Strategy

Acme Generics Private Limited — Manufacturing & Regulatory Profile

1FDA Status

2WHO & EU GMP

3CDSCO & Indian Regulatory

4Recent Regulatory Actions

Acme Generics Private Limited — Competitive Positioning Among Indian Pharma Exporters

1Competitive Landscape

2Key Differentiators

3Strategic Position

Buyer Due Diligence Brief — Evaluating Acme Generics Private Limited as a Supplier

1Supplier Assessment

2Certifications to Verify

3Due Diligence Checklist

Frequently Asked Questions — Acme Generics Private Limited

How many pharmaceutical products does Acme Generics Private Limited export from India?

What is Acme Generics Private Limited's total pharmaceutical export value?

What therapeutic categories does Acme Generics Private Limited cover?

Get Full Acme Generics Private Limited Export Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Data Source & Methodology